1 / 6

SARS-CoV-2 VLP Recombinant Protein

SARS-CoV-2 VLP Recombinant Protein for students,scholars,researchers...

Joannaz
Download Presentation

SARS-CoV-2 VLP Recombinant Protein

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SARS-CoV-2 VLP Recombinant Protein

  2. SARS-CoV-2 has similar structural features to other coronaviruses. Coronavirus particles have four main structural proteins, namely membrane (M) protein, nucleocapsid (N) protein, spike (S) protein, and envelope (E) protein, and several accessory proteins. Non-infectious virus-like particles (VLPs) displaying crucial viral proteins can be utilized to investigate the structural properties of natural viruses. Besides, VLPs do not contain any viral genetic material and have the potential to trigger a powerful immune response, offering a much safer option for vaccine development.

  3. In the current continuous outbreak of SARS-CoV-2 / COVID-19, as an advanced VLP supplier, Creative Biostructureprovides several VLP products in the family Coronaviridae. Currently, we have successfully created SARS-CoV-2 VLPs composed of M, N, S, and E in mammalian cells. Listed below are some of our COVID-19 related VLP products.

  4. We offer highly purified COVID-19 related VLP products as antigens for research use only, mostly using a mammalian expression system. Creative Biostructure has rich experience in the production of VLPs and can provide custom VLP synthesis services according to your experimental goals. In addition, Creative Biostructure has established a dedicated coronavirus service platform to assist researchers in basic research on coronavirus bioinformatics analysis, viral particle identification and characterization, coronavirus-related protein interaction analysis, and protein structural analysis. We also provide preclinical antiviral drug discovery and vaccine development services. Please do not hesitate to contact us for further information or a detailed quote. Reference: Kim D, et al. The architecture of SARS-CoV-2 transcriptome. Cell. 2020, 181(4): 914-921. e10.

  5. Thank you ! Excerpt from: https://www.creative-biostructure.com/COVID-19-Related-VLP-Products-674.htm

More Related